Literature DB >> 17521950

Young onset Hemifacial Spasm in patients with Chiari type I malformation.

Andre Carvalho Felício1, Clecio de Godeiro, Vanderci Borges, Sonia Maria de Azevedo Silva, Henrique Ballalai Ferraz.   

Abstract

Hemifacial spasm (HFS) resulting from Chiari type I malformation (CIM) is rare. We retrospectively evaluated five patients with CIM and HFS among a series of 103 subjects. The frequency of HFS associated to CIM was of 4.85%. The clinical profile did not differ from the classical primary cases except for young-onset development of facial spasms in patients with CIM. Three patients were treated with BTX-A injections with favorable outcome. Although rare HFS may be associated with CIM especially in young subjects with peculiar phenotypic characteristics (short neck). Moreover, BTX may be an alternative to posterior fossa decompression in selected cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521950     DOI: 10.1016/j.parkreldis.2007.04.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  4 in total

1.  Clinical diagnosis-part II: what is attributed to Chiari I.

Authors:  Federica Novegno
Journal:  Childs Nerv Syst       Date:  2019-05-15       Impact factor: 1.475

2.  Hemifacial spasm associated with type 1 Chiari malformation: a retrospective study of 13 cases.

Authors:  Ning Li; Wei-Guo Zhao; Chun-Hua Pu; Wen-Lei Yang
Journal:  Neurosurg Rev       Date:  2016-07-15       Impact factor: 3.042

Review 3.  Hemifacial spasm and neurovascular compression.

Authors:  Alex Y Lu; Jacky T Yeung; Jason L Gerrard; Elias M Michaelides; Raymond F Sekula; Ketan R Bulsara
Journal:  ScientificWorldJournal       Date:  2014-10-28

4.  Microvascular Decompression in Patients Aged 30 Years or Younger.

Authors:  Prasanna Karki; Masayuki Yamagami; Koji Takasaki; Manoj Bohara; Hiroshi Hosoyama; Tomoko Hanada; Fumiyuki Yamasaki; Ryosuke Hanaya; Kazunori Arita
Journal:  Asian J Neurosurg       Date:  2019 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.